OnKure Therapeutics, Inc. (OKUR)
Nasdaq: OKUR · Pharmaceutical Preparations · Boulder, CO · filing with the SEC since 2018
Who runs OnKure Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Saccomano Nicholas A
President and CEO. First filing Oct 2024, latest Sep 23, 2026, 7 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
27 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Saccomano Nicholas A | President and CEO | Oct 2024 | Sep 23, 2026 | 4 · $0.00 |
| Leverone Jason A. | Chief Financial Officer | Oct 2024 | Sep 23, 2026 | 4 · $0.00 |
| Grey Michael G | Executive Chairman | Apr 2021 | Aug 11, 2026 | none |
| Agresta Samuel | Chief Medical Officer | Oct 2024 | Aug 11, 2026 | none |
| Hartley Dylan | Chief Scientific Officer | Oct 2024 | Aug 11, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Manke Isaac | director | Oct 2024 | Aug 13, 2026 | none |
| Carruthers R Michael | director | Oct 2024 | Aug 11, 2026 | none |
| Jansen Valerie Malyvanh | director | Oct 2024 | Aug 11, 2026 | none |
| Mathers Edward T | director | Apr 2021 | Aug 11, 2026 | none |
| Phillips Andrew John | director | Oct 2024 | Aug 11, 2026 | none |
| Ratcliffe Liam | director | Apr 2026 | Aug 11, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Access Industries Holdings LLC | 10% owner | Apr 2026 | Apr 7, 2026 | none |
| Access Industries Management, LLC | 10% owner | Apr 2026 | Apr 7, 2026 | none |
| Ai Biotechnology LLC | 10% owner | Apr 2026 | Apr 7, 2026 | none |
| Blavatnik Len | 10% owner | Apr 2026 | Apr 7, 2026 | none |
Earlier names on the record32, newest filing first
Acorn Bioventures 2, L.P. · 10% owner · last filing May 2025Acorn Capital Advisors Gp 2, LLC · 10% owner · last filing May 2025Acorn Bioventures, L.P. · 10% owner · last filing May 2025Acorn Capital Advisors Gp, LLC · 10% owner · last filing May 2025Chen Bihua · 10% owner · last filing May 2025Cormorant Asset Management, LP · 10% owner · last filing May 2025Cormorant Global Healthcare Master Fund, LP · 10% owner · last filing May 2025Cormorant Private Healthcare Fund III LP · 10% owner · last filing May 2025Cormorant Private Healthcare Fund IV LP · 10% owner · last filing May 2025Cormorant Private Healthcare Fund V LP · 10% owner · last filing May 2025Hove Anders D · 10% owner · last filing May 2025Leonard Braden Michael · 10% owner · last filing Oct 2024Hall Ashley · officer · last filing Aug 2023Novo Holdings A/s · 10% owner · last filing Jun 2023Blunt Roshawn A. · director · last filing Jun 2023Dube Eric M · director · last filing Jun 2023Hoelscher Paul W. · director · last filing Jun 2023Muralidhar Bali · director · last filing Jun 2023O'Donnell Niall · director · last filing Jun 2023Seltzer Stacey Denenberg · director · last filing Jun 2023Flesher Gregory J. · officer · last filing Dec 2022Cruse Michael · officer · last filing Dec 2022Dorenbaum Alejandro · officer · last filing Dec 2022Lam Jennifer · officer · last filing Dec 2022Jindal Vineet R. · officer · last filing Dec 2021Johnson Wendy S. · officer · last filing Jul 2021Harrison Kenneth Ph.D. · director · last filing May 2021Baskett Forest · 10% owner · last filing Apr 2021Florence Anthony A. Jr. · 10% owner · last filing Apr 2021Makhzoumi Mohamad · 10% owner · last filing Apr 2021Cardon Lon · director · last filing Apr 2021Kordel Johan · director · last filing Apr 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.